Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth Japan Appoints New President

This article was originally published in PharmAsia News

Executive Summary

Michael Goettler took over as Wyeth Japan president Sept. 17; he replaced Susumu Kurata, who will remain as an executive director until Sept. 30. At the age of 41, Goettler worked at Hoechst AG, Aventis Pharmaceutical before he became marketing division head for Sanofi Aventis in 2005. He later served as the vice president for Wyeth Pharmaceuticals' biopharma division, and in 2008 he assumed the role of marketing vice president in charge of opioid constipation drug Relistor (methylnaltrexone). (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069677

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel